Skip to main content
Top
Published in: BMC Urology 1/2014

Open Access 01-12-2014 | Case report

A rare case of unilateral adrenal hyperplasia accompanied by hypokalaemic periodic paralysis caused by a novel dominant mutation in CACNA1S: features and prognosis after adrenalectomy

Authors: Bo Yang, Yuan Yang, Wenling Tu, Ying Shen, Qiang Dong

Published in: BMC Urology | Issue 1/2014

Login to get access

Abstract

Background

Acute hypokalaemic paralysis is characterised by acute flaccid muscle weakness and has a complex aetiological spectrum. Herein we report, for the first time, a case of unilateral adrenal hyperplasia accompanied by hypokalaemic periodic paralysis type I resulting from a novel dominant mutation in CACNA1S. We present the clinical features and prognosis after adrenalectomy in this case.

Case presentation

A 43-year-old Han Chinese male presented with severe hypokalaemic paralysis that remitted after taking oral potassium. The patient had suffered from periodic attacks of hypokalaemic paralysis for more than 20 years. A computed tomography (CT) scan of the abdomen showed a nodular mass on the left adrenal gland, although laboratory examination revealed the patient had not developed primary aldosteronism. The patient underwent a left adrenalectomy 4 days after admission, and the pathological examination further confirmed a 1.1 cm benign nodule at the periphery of the adrenal gland. Three months after the adrenalectomy, a paralytic attack recurred and the patient asked for assistance from the Department of Medical Genetics. His family history showed that two uncles, one brother, and a nephew also had a history of periodic paralysis, although their symptoms were milder. The patient’s CACNA1S and SCN4A genes were sequenced, and a novel missense mutation, c.1582C > T (p.Arg528Cys), in CACNA1S was detected. Detection of the mutation in five adult male family members, including three with periodic paralysis and two with no history of the disease, indicated that this mutation caused hypokalaemic periodic paralysis type I in his family. Follow-up 2 years after adrenalectomy showed that the serum potassium concentration was increased between paralyses and the number and severity of paralytic attacks were significantly decreased.

Conclusion

We identified a novel dominant mutation, c.1582C > T (p.Arg528Cys), in CACNA1S that causes hypokalaemic periodic paralysis. The therapeutic effect of adrenalectomy indicated that unilateral adrenal hyperplasia might make paralytic attacks more serious and more frequent by decreasing serum potassium. This finding suggests that the surgical removal of hyperplastic tissues might relieve the symptoms of patients with severe hypokalaemic paralysis caused by other incurable diseases, even if the adrenal lesion does not cause primary aldosteronism.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jiang SB, Guo XD, Wang HB, Gong RZ, Xiong H, Wang Z, Zhang HY, Jin XB: A retrospective study of laparoscopic unilateral adrenalectomy for primary hyperaldosteronism caused by unilateral adrenal hyperplasia. Int Urol Nephrol. 2014, 46: 1283-1288. 10.1007/s11255-013-0614-9.CrossRefPubMed Jiang SB, Guo XD, Wang HB, Gong RZ, Xiong H, Wang Z, Zhang HY, Jin XB: A retrospective study of laparoscopic unilateral adrenalectomy for primary hyperaldosteronism caused by unilateral adrenal hyperplasia. Int Urol Nephrol. 2014, 46: 1283-1288. 10.1007/s11255-013-0614-9.CrossRefPubMed
2.
go back to reference Sigurjonsdottir HA, Gronowitz M, Andersson O, Eggertsen R, Herlitz H, Sakinis A, Wangberg B, Johannsson G: Unilateral adrenal hyperplasia is a usual cause of primary hyperaldosteronism. Results from a Swedish screening study. BMC Endocr Disord. 2012, 12: 17-10.1186/1472-6823-12-17.CrossRefPubMedPubMedCentral Sigurjonsdottir HA, Gronowitz M, Andersson O, Eggertsen R, Herlitz H, Sakinis A, Wangberg B, Johannsson G: Unilateral adrenal hyperplasia is a usual cause of primary hyperaldosteronism. Results from a Swedish screening study. BMC Endocr Disord. 2012, 12: 17-10.1186/1472-6823-12-17.CrossRefPubMedPubMedCentral
3.
go back to reference Iacobone M, Citton M, Viel G, Boetto R, Bonadio I, Tropea S, Mantero F, Rossi GP, Fassina A, Nitti D, Favia G: Unilateral adrenal hyperplasia: a novel cause of surgically correctable primary hyperaldosteronism. Surgery. 2012, 152: 1248-1255. 10.1016/j.surg.2012.08.042.CrossRefPubMed Iacobone M, Citton M, Viel G, Boetto R, Bonadio I, Tropea S, Mantero F, Rossi GP, Fassina A, Nitti D, Favia G: Unilateral adrenal hyperplasia: a novel cause of surgically correctable primary hyperaldosteronism. Surgery. 2012, 152: 1248-1255. 10.1016/j.surg.2012.08.042.CrossRefPubMed
4.
go back to reference Huang YY, Hsu BR, Tsai JS: Paralytic myopathy-a leading clinical presentation for primary aldosteronism in Taiwan. J Clin Endocrinol Metab. 1996, 81: 4038-4041.PubMed Huang YY, Hsu BR, Tsai JS: Paralytic myopathy-a leading clinical presentation for primary aldosteronism in Taiwan. J Clin Endocrinol Metab. 1996, 81: 4038-4041.PubMed
5.
go back to reference Elbaz A, Vale-Santos J, Jurkat-Rott K, Lapie P, Ophoff RA, Bady B, Links TP, Piussan C, Vila A, Monnier N, Padberg GW, Abe K, Feingold N, Guimaraes J, Wintzen AR, van der Hoeven JH, Saudubray JM, Grunfeld JP, Lenoir G, Nivet H, Echenne B, Frants RR, Fardeau M, Lehmann-Horn F, Fontaine B: Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 caucasian families. Am J Hum Genet. 1995, 56: 374-380. 10.1002/ajmg.1320560406.CrossRefPubMedPubMedCentral Elbaz A, Vale-Santos J, Jurkat-Rott K, Lapie P, Ophoff RA, Bady B, Links TP, Piussan C, Vila A, Monnier N, Padberg GW, Abe K, Feingold N, Guimaraes J, Wintzen AR, van der Hoeven JH, Saudubray JM, Grunfeld JP, Lenoir G, Nivet H, Echenne B, Frants RR, Fardeau M, Lehmann-Horn F, Fontaine B: Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 caucasian families. Am J Hum Genet. 1995, 56: 374-380. 10.1002/ajmg.1320560406.CrossRefPubMedPubMedCentral
6.
go back to reference Sternberg D, Maisonobe T, Jurkat-Rott K, Nicole S, Launay E, Chauveau D, Tabti N, Lehmann-Horn F, Hainque B, Fontaine B: Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A. Brain. 2001, 124: 1091-1099. 10.1093/brain/124.6.1091.CrossRefPubMed Sternberg D, Maisonobe T, Jurkat-Rott K, Nicole S, Launay E, Chauveau D, Tabti N, Lehmann-Horn F, Hainque B, Fontaine B: Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A. Brain. 2001, 124: 1091-1099. 10.1093/brain/124.6.1091.CrossRefPubMed
7.
go back to reference Fontaine B, Vale-Santos J, Jurkat-Rott K, Reboul J, Plassart E, Rime CS, Elbaz A, Heine R, Guimarães J, Weissenbach J, Baumann N, Fardeau M, Lehmann-Horn F: Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31-32 in three European families. Nat Genet. 1994, 6: 267-272. 10.1038/ng0394-267.CrossRefPubMed Fontaine B, Vale-Santos J, Jurkat-Rott K, Reboul J, Plassart E, Rime CS, Elbaz A, Heine R, Guimarães J, Weissenbach J, Baumann N, Fardeau M, Lehmann-Horn F: Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31-32 in three European families. Nat Genet. 1994, 6: 267-272. 10.1038/ng0394-267.CrossRefPubMed
8.
go back to reference Bulman DE, Scoggan KA, van Oene MD, Nicolle MW, Hahn AF, Tollar LL, Ebers GC: A novel sodium channel mutation in a family with hypokalemic periodic paralysis. Neurology. 1999, 53: 1932-1936. 10.1212/WNL.53.9.1932.CrossRefPubMed Bulman DE, Scoggan KA, van Oene MD, Nicolle MW, Hahn AF, Tollar LL, Ebers GC: A novel sodium channel mutation in a family with hypokalemic periodic paralysis. Neurology. 1999, 53: 1932-1936. 10.1212/WNL.53.9.1932.CrossRefPubMed
9.
go back to reference Weiner ID, Wingo CS: Hypokalemia-consequences, causes, and correction. J Am Soc Nephrol. 1997, 8: 1179-1188.PubMed Weiner ID, Wingo CS: Hypokalemia-consequences, causes, and correction. J Am Soc Nephrol. 1997, 8: 1179-1188.PubMed
10.
go back to reference Kayal AK, Goswami M, Das M, Jain R: Clinical and biochemical spectrum of hypokalemic paralysis in North: East India. Ann Indian Acad Neurol. 2013, 16: 211-217. 10.4103/0972-2327.112469.CrossRefPubMedPubMedCentral Kayal AK, Goswami M, Das M, Jain R: Clinical and biochemical spectrum of hypokalemic paralysis in North: East India. Ann Indian Acad Neurol. 2013, 16: 211-217. 10.4103/0972-2327.112469.CrossRefPubMedPubMedCentral
11.
go back to reference Morrill JA, Cannon SC: Effects of mutations causing hypokalaemic periodic paralysis on the skeletal muscle L-type Ca2+ channel expressed in Xenopus laevis oocytes. J Physiol. 1999, 520: 321-336. 10.1111/j.1469-7793.1999.00321.x.CrossRefPubMedPubMedCentral Morrill JA, Cannon SC: Effects of mutations causing hypokalaemic periodic paralysis on the skeletal muscle L-type Ca2+ channel expressed in Xenopus laevis oocytes. J Physiol. 1999, 520: 321-336. 10.1111/j.1469-7793.1999.00321.x.CrossRefPubMedPubMedCentral
12.
go back to reference Jurkat-Rott K, Mitrovic N, Hang C, Kouzmekine A, Iaizzo P, Herzog J, Lerche H, Nicole S, Vale-Santos J, Chauveau D, Fontaine B, Lehmann-Horn F: Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci U S A. 2000, 97: 9549-9554. 10.1073/pnas.97.17.9549.CrossRefPubMedPubMedCentral Jurkat-Rott K, Mitrovic N, Hang C, Kouzmekine A, Iaizzo P, Herzog J, Lerche H, Nicole S, Vale-Santos J, Chauveau D, Fontaine B, Lehmann-Horn F: Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci U S A. 2000, 97: 9549-9554. 10.1073/pnas.97.17.9549.CrossRefPubMedPubMedCentral
13.
go back to reference Wang Q, Liu M, Xu C, Tang Z, Liao Y, Du R, Li W, Wu X, Wang X, Liu P, Zhang X, Zhu J, Ren X, Ke T, Wang Q, Yang J: Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a Chinese family. J Mol Med (Berl). 2005, 83: 203-208. 10.1007/s00109-005-0638-4.CrossRef Wang Q, Liu M, Xu C, Tang Z, Liao Y, Du R, Li W, Wu X, Wang X, Liu P, Zhang X, Zhu J, Ren X, Ke T, Wang Q, Yang J: Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a Chinese family. J Mol Med (Berl). 2005, 83: 203-208. 10.1007/s00109-005-0638-4.CrossRef
14.
go back to reference Kotsaftis P, Savopoulos C, Agapakis D, Ntaios G, Tzioufa V, Papadopoulos V, Fahantidis E, Hatzitolios A: Hypokalemia induced myopathy as first manifestation of primary hyperaldosteronism - an elderly patient with unilateral adrenal hyperplasia: a case report. Cases J. 2009, 2: 6813-10.4076/1757-1626-2-6813.CrossRefPubMedPubMedCentral Kotsaftis P, Savopoulos C, Agapakis D, Ntaios G, Tzioufa V, Papadopoulos V, Fahantidis E, Hatzitolios A: Hypokalemia induced myopathy as first manifestation of primary hyperaldosteronism - an elderly patient with unilateral adrenal hyperplasia: a case report. Cases J. 2009, 2: 6813-10.4076/1757-1626-2-6813.CrossRefPubMedPubMedCentral
15.
go back to reference Amar L, Plouin PF, Steichen O: Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism. Orphanet J Rare Dis. 2010, 5: 9-10.1186/1750-1172-5-9.CrossRefPubMedPubMedCentral Amar L, Plouin PF, Steichen O: Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism. Orphanet J Rare Dis. 2010, 5: 9-10.1186/1750-1172-5-9.CrossRefPubMedPubMedCentral
16.
go back to reference Ng HY, Lin SH, Hsu CY, Tsai YZ, Chen HC, Lee CT: Hypokalemic paralysis due to Gitelman syndrome: a family study. Neurology. 2006, 67: 1080-1082. 10.1212/01.wnl.0000237527.27595.87.CrossRefPubMed Ng HY, Lin SH, Hsu CY, Tsai YZ, Chen HC, Lee CT: Hypokalemic paralysis due to Gitelman syndrome: a family study. Neurology. 2006, 67: 1080-1082. 10.1212/01.wnl.0000237527.27595.87.CrossRefPubMed
Metadata
Title
A rare case of unilateral adrenal hyperplasia accompanied by hypokalaemic periodic paralysis caused by a novel dominant mutation in CACNA1S: features and prognosis after adrenalectomy
Authors
Bo Yang
Yuan Yang
Wenling Tu
Ying Shen
Qiang Dong
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Urology / Issue 1/2014
Electronic ISSN: 1471-2490
DOI
https://doi.org/10.1186/1471-2490-14-96

Other articles of this Issue 1/2014

BMC Urology 1/2014 Go to the issue